Vimarsana
Biggest News Aggregation in the World

Page 5 - Mark Gergen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Gergen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Gergen Today - Breaking & Trending Today

Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy - Vimarsana News

Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy

SAN DIEGO, Feb. 22, 2022 /PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprieta...

Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy - Vimarsana News

Poseida Therapeutics Appoints Brent Warner as President, Gene Therapy

/PRNewswire/ -- Poseida Therapeutics, Inc. (NASDAQ: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform...

Poseida Therapeutics Announces Eric Ostertag to Serve as Executive Chairman and Transition Role of CEO to Current President and CBO Mark Gergen - Vimarsana News

Poseida Therapeutics Announces Eric Ostertag to Serve as Executive Chairman and Transition Role of CEO to Current President and CBO Mark Gergen

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...

Poseida Therapeutics Announces Eric Ostertag to Serve as Executive Chairman and Transition Role of CEO to Current President and CBO Mark Gergen - Vimarsana News

Poseida Therapeutics Announces Eric Ostertag to Serve as Executive Chairman and Transition Role of CEO to Current President and CBO Mark Gergen

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Poseida Therapeutics Announces Leadership Appointments - Vimarsana News

Poseida Therapeutics Announces Leadership Appointments

/PRNewswire/ -- Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform...